Standing brief
Temple Protocol is a research-grade editorial practice in the field of longevity medicine. We synthesize current literature on supplements, peptides, and aging interventions for adults who are actively engaged with their health practice.
We are not a supplement brand, a clinic, or an influencer operation. We are editorial: every claim traces to a source, every confidence label is honest, every piece of content is conditional. The methodology is published at templeprotocol.ai/evidence.
The first product — the Bio Stack Audit — is an AI-assisted interaction and confidence review for supplement and peptide stacks. It is in development, pending legal and clinical review. It is not a medical device and does not provide medical advice.
Temple Protocol is a brand of Echelon Seven LLC, based in Nashville, Tennessee. Founder: Aaron De Young.